Analysis: How stocks will fare in ruling on health care law
The Supreme Court is expected to rule on the Affordable Care Act by the end of June. Here’s a roundup of how health care businesses would be affected under four different scenarios.
Health Care & Insurance
Articles
Notre Dame receives $5M for adult stem cell research
The university says the gift from an alumnus will fund three new endowed professorships in adult and all forms of non-embryonic stem cell research, in hopes of accelerating discovery of new treatments for heart disease, diabetes and some cancers.
Indiana smoking ban brings new sign rules
To comply with the statewide smoking ban that begins July 1, there's more for businesses to do than stop patrons and employees from smoking indoors. The same law compels businesses to post an array of signs that announce the ban.
J&J, Bayer fail to win U.S. OK for expanded Xarelto use
If approved for acute coronary syndrome, Xarelto would compete with Effient from Indianapolis-based Eli Lilly and Co and Brilinta from London-based AstraZeneca Plc.
Medical startup plans 71 jobs, seeks incentives
The city of Indianapolis granted preliminary approval for an eight-year tax abatement to Arcamed Inc., which plans to purchase $1.4 million in equipment to design and manufacture titanium and case-tray systems for surgical instruments.
Lilly resumes $3B stock buyback program, declares dividend
The local pharmaceutical giant plans to complete the program started in 2000 by repurchasing $420 million in shares by the end of the year. And on Tuesday, it declared a regular dividend of 49 cents.
Court ruling would lift cloud of uncertainty
The U.S. Supreme Court did not hand down a ruling in the health care reform case Monday morning. The nine justices meet again Thursday, but most observers expect the decision to come June 25 or June 28.
Biomet gives ortho industry hope
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
WellPoint lowers earnings forecast after $90M legal bill
Indianapolis-based WellPoint Inc. said it is lowering its profit forecast for the year by 3 percent after reaching a $90 million settlement in a class-action lawsuit.
WellPoint settlement: $90M for former Anthem members
The federal lawsuit was set to go to trial June 18 in Indianapolis. The claims arise from Anthem’s 2001 conversion from a mutual company, owned by its insured policyholders, to a public company.
Veteran hospital exec Odle to retire from IU Health
Sam Odle, one of Indianapolis’ most prominent black business leaders, will be replaced on an interim basis by Jim Terwilliger while the hospital system conducts a national search for his successor.
Little Red Door absorbs program of group that’s disbanding
Fishers-based Cancer-Free Lungs decided last year it was ready to shut down.
Benefits brokers gain ground without merging
While mergers and acquisitions have been rampant in central Indiana’s benefits-broker industry the past five years, a handful of brokers has grown the old-fashioned way—by adding clients.
Fired St. Vincent physician suing hospital for discrimination
The Indian-born doctor is seeking past and future pay, in addition to other damages, for enduring what she considers harassment and discrimination while a resident at the Indianapolis hospital.
Web domain requests include .Cialis, .Walmart
Indianapolis-based Eli Lilly and Co. and other corporate heavyweights are applying for Web suffixes including .cialis, .walmart and .jpmorgan under a program to expand the number of Internet domain names beyond .com.
Lilly sinks $20M into Chinese firm for ‘branded generic’ drugs
Eli Lilly and Co. has invested $20 million in Chinese pharmaceutical company Novast Labs in an effort to build up a portfolio of branded generic medicines in the fast-growing Asian market.
WellPoint rivals to keep parts of health care law
Some of the nation's biggest health insurers will keep some popular parts of President Barack Obama's health care overhaul even if the law fails to survive U.S. Supreme Court scrutiny later this month. Indianapolis-based WellPoint will wait for the court ruling.
Lilly chases Novo in insulin race
Eli Lilly and Co. announced positive results for an experiemental insulin at the annual American Diabetes Association conference in Philadelphia, but was still upstaged by Denmark-based Novo Nordisk A/S.
Employers slow to act on health reform
Even though employers expect the U.S. Supreme Court to strike down at least some of the 2010 health reform law later this month, few are actually doing any contingency planning.
House swipes at health law with repeal of medical device tax
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.